vida: extract from 2025-00-00-nhs-england-waiting-times-underfunding.md

- Source: inbox/archive/2025-00-00-nhs-england-waiting-times-underfunding.md
- Domain: health
- Extracted by: headless extraction cron (worker 2)

Pentagon-Agent: Vida <HEADLESS>

domains/health/chronic-underfunding-of-healthcare-capital-compounds-exponentially-as-263-percent-respiratory-wait-growth-demonstrates.md

@@ -1,57 +0,0 @@
----
-type: claim
-domain: health
-description: "NHS respiratory wait times grew 263% over a decade while gynaecology grew 223%, showing underfunding creates exponential degradation not linear decline"
-confidence: experimental
-source: "UK Parliament Public Accounts Committee (2024-2025)"
-created: 2026-03-11
----
-
-# Chronic underfunding of healthcare capital compounds exponentially as 263 percent respiratory wait growth demonstrates
-
-Healthcare capacity constraints don't degrade linearly—they compound. The NHS demonstrates this through specialty-specific waiting list growth over the past decade:
-
-- Respiratory medicine: **263% increase** in waiting list size
-- Gynaecology: **223% increase**
-- Overall waiting list: 7.5M patients, must be halved to 3.4M to reach target
-- Diagnostic shortfall: **3.6 million tests** behind demand
-
-This exponential growth pattern suggests that underfunding creates a doom loop: longer waits → sicker patients at presentation → more complex/expensive treatment → fewer patients treated per unit capacity → longer waits.
-
-The NHS spent billions on "recovery programs" and "transformation initiatives" without outcome improvement, indicating that incremental funding cannot reverse exponential degradation once the system crosses a threshold.
-
-## Evidence
-
-**Structural underfunding:**
-- Chronic capital underfunding relative to demand growth
-- Workforce shortages in specialist care
-- High competition for specialty training positions
-
-**Failed recovery attempts:**
-- Diagnostic and surgical transformation programs received billions
-- No measurable improvement in waiting times or outcomes
-- Target of 65% within 18 weeks by March 2026 unlikely to be met
-
-**Gatekeeping amplifies the problem:**
-- GP referral requirement (gatekeeping) improves primary care metrics
-- But creates bottlenecks at the specialty interface
-- Single-payer administrative efficiency doesn't translate to specialty delivery efficiency
-
-## Mechanism and Limitations
-
-The compounding effect likely operates through multiple channels:
-1. **Clinical deterioration:** Patients waiting longer present with more advanced disease
-2. **Capacity erosion:** Staff burnout and emigration reduce effective capacity
-3. **Demand induction:** Poor outcomes create need for additional interventions
-4. **Political inertia:** Gradual degradation is less visible than acute crisis
-
-This claim is rated **experimental** because the exponential growth pattern is observed but the causal mechanism (underfunding specifically, vs. gatekeeping, vs. workforce dynamics) is not isolated. The data shows correlation, not proof of exponential compounding as a universal principle.
-
----
-
-Relevant Notes:
-- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]] — specialty wait times may matter less than assumed if medical care is only 10-20% of outcomes
-- [[the healthcare cost curve bends up through 2035 because new curative and screening capabilities create more treatable conditions faster than prices decline]] — NHS shows what happens when capability expansion meets funding constraint
-
-Topics:
-- [[domains/health/_map]]

domains/health/gatekeeping-primary-care-models-improve-equity-and-primary-outcomes-but-create-specialty-bottlenecks-when-capacity-is-underfunded.md

@@ -0,0 +1,58 @@
+---
+type: claim
+domain: health
+description: "GP-referral gatekeeping strengthens primary care and equity but becomes an access barrier when specialty capacity doesn't match demand"
+confidence: likely
+source: "NHS England structural analysis, UK Parliament Public Accounts Committee (2024-2025)"
+created: 2025-01-15
+---
+
+# Gatekeeping primary care models improve equity and primary outcomes but create specialty bottlenecks when capacity is underfunded
+
+The NHS gatekeeping model—where patients must see a GP before accessing specialty care—demonstrates a fundamental tradeoff in healthcare system design. Gatekeeping strengthens primary care by:
+1. Ensuring all patients have a primary care relationship
+2. Reducing inappropriate specialty referrals
+3. Improving equity of access to primary services
+4. Creating continuity of care
+
+This design contributes to the NHS's high rankings on primary care quality and equity metrics in international comparisons (Commonwealth Fund Mirror Mirror 2024: 3rd overall).
+
+However, gatekeeping converts specialty capacity constraints into access barriers. When specialty capacity is underfunded relative to demand, the referral requirement doesn't reduce demand—it just queues it. The NHS demonstrates this failure mode:
+- Only 58.9% of 7.5M waiting patients seen within 18 weeks (target: 92%)
+- Waiting list must be halved to 3.4M to reach the 92% standard
+- Some specialties (respiratory medicine: 263% growth; gynaecology: 223% growth) show exponential degradation
+
+The gatekeeping model works when specialty capacity matches referral volume. It fails when chronic underfunding creates a mismatch. The GP becomes a bottleneck manager rather than a care coordinator, and patients experience the worst of both worlds: delayed primary care access (to see the GP) followed by delayed specialty access (after referral).
+
+This is not an argument against gatekeeping—it's an argument that gatekeeping requires adequate specialty capacity funding to function as designed. The NHS proves that structural design choices (gatekeeping) and resource allocation (specialty funding) must be matched, or the system degrades.
+
+## Evidence
+
+**Gatekeeping benefits (demonstrated in NHS structure):**
+- Universal primary care coverage (100% of population has GP access)
+- High equity scores in international comparisons (Commonwealth Fund 2024)
+- Strong GP-patient relationships enable continuity of care
+- Ranked 3rd overall in Commonwealth Fund Mirror Mirror 2024
+
+**Specialty bottleneck evidence:**
+- 58.9% of 7.5M patients seen within 18 weeks (target: 92%)
+- 22% wait >6 weeks for diagnostic tests (standard: 1%)
+- Respiratory medicine: 263% increase in waiting list size over past decade
+- Gynaecology: 223% increase
+- Shortfall of 3.6 million diagnostic tests
+- Chronic capital underfunding relative to demand
+- Workforce shortages in specialist care
+
+**System degradation pattern:**
+- Billions spent on recovery programs without outcomes improvement
+- Target of 65% within 18 weeks by March 2026 unlikely to be met
+- Exponential growth in wait times shows compounding failure
+
+---
+
+Relevant Notes:
+- [[nhs-demonstrates-universal-coverage-can-coexist-with-poor-specialty-outcomes-because-primary-care-equity-and-specialty-access-are-independent-dimensions]]
+- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]
+
+Topics:
+- [[domains/health/_map]]

domains/health/gatekeeping-through-gp-referral-requirements-improves-primary-care-quality-but-creates-specialty-access-bottlenecks.md

@@ -1,56 +0,0 @@
----
-type: claim
-domain: health
-description: "NHS GP gatekeeping contributes to strong primary care rankings but worst specialty wait times among peer nations, showing structural tradeoff between coordination and access"
-confidence: experimental
-source: "UK Parliament Public Accounts Committee, BMA, NHS England (2024-2025); Commonwealth Fund Mirror Mirror 2024"
-created: 2026-03-11
----
-
-# Gatekeeping through GP referral requirements improves primary care quality but creates specialty access bottlenecks
-
-The NHS requires GP referral for specialty access (gatekeeping), which creates a structural tradeoff:
-
-**Primary care benefits:**
-- Strong continuity of care
-- Coordination across conditions
-- Appropriate utilization (fewer unnecessary specialty visits)
-- Contributes to NHS ranking 3rd overall in Commonwealth Fund assessment
-
-**Specialty access costs:**
-- Only **58.9%** of patients seen within 18-week target (goal: 92%)
-- **22%** waiting >6 weeks for diagnostic tests (standard: 1%)
-- Worst specialty access among peer nations in Mirror Mirror comparison
-- 263% growth in respiratory wait times, 223% in gynaecology over a decade
-
-This suggests gatekeeping is not a pure efficiency gain—it shifts the constraint from specialty overutilization to specialty access delay. Whether this tradeoff is worthwhile depends on:
-1. The relative harm of unnecessary vs. delayed specialty care
-2. Whether the primary care coordination benefits justify the specialty access costs
-3. System capacity—gatekeeping may work well in well-funded systems but amplify problems in underfunded ones
-
-## Evidence
-
-The NHS combines:
-- Universal coverage
-- Strong primary care (GP-centered model with gatekeeping)
-- Single-payer administrative efficiency
-- Chronic capital underfunding
-
-The result is high marks for equity and primary care, but catastrophic specialty performance. This pattern is distinct from the US (weak primary care, strong specialty access for insured) and suggests the gatekeeping structure interacts with funding levels.
-
-## Limitations
-
-This claim is rated **experimental** because:
-1. We don't have a clean counterfactual (NHS without gatekeeping, all else equal)
-2. Underfunding may be the primary cause, with gatekeeping merely amplifying it
-3. Other single-payer systems with gatekeeping (e.g., Netherlands, Germany) don't show the same specialty degradation, suggesting gatekeeping alone is not sufficient to cause the observed bottleneck
-4. The mechanism is plausible but not proven: gatekeeping + underfunding = compounding delay
-
----
-
-Relevant Notes:
-- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]] — if medical care is only 10-20% of outcomes, specialty wait times may matter less than primary care quality
-- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] — gatekeeping is a coordination mechanism that works better when payment aligns with outcomes
-
-Topics:
-- [[domains/health/_map]]

domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md

@@ -33,7 +33,7 @@ This has structural implications for how healthcare should be organized. Since [
 ### Additional Evidence (extend)
 *Source: [[2025-00-00-nhs-england-waiting-times-underfunding]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
 
-(Extend) The NHS paradox provides a natural experiment for the medical care contribution question. Despite having the worst specialty access and longest wait times among peer nations (only 58.9% seen within 18 weeks, 263% growth in respiratory waits over a decade), the NHS ranks 3rd overall in Commonwealth Fund Mirror Mirror 2024. This suggests that specialty medical care quality may matter less to population health than primary care, equity, and universal coverage—consistent with the 10-20% medical care contribution claim. If specialty access were a dominant factor in health outcomes, the NHS would rank far lower overall. However, this is correlational evidence; the NHS's high ranking may reflect Commonwealth Fund methodology weighting rather than true population health outcomes.
+(extend) The NHS case provides a natural experiment showing that even when medical care access is universal and equitable at the primary care level, specialty care bottlenecks severely limit the system's ability to deliver the 10-20% of health outcomes that medical care can influence. With only 58.9% of 7.5M waiting patients seen within 18 weeks and 263% growth in respiratory medicine wait times over a decade, the NHS demonstrates that access to primary care doesn't guarantee access to the specialty interventions (cardiology, oncology, orthopedics) that drive medical care's contribution to health outcomes. This suggests the 10-20% figure may represent an upper bound in systems with unconstrained specialty access, and may overstate medical care's impact in systems where specialty access is severely constrained, even when primary care is universal and equitable.
 
 ---
 

domains/health/nhs-demonstrates-universal-coverage-can-coexist-with-poor-specialty-outcomes-because-primary-care-equity-and-specialty-access-are-independent-dimensions.md

@@ -0,0 +1,63 @@
+---
+type: claim
+domain: health
+description: "The NHS ranks 3rd overall in Commonwealth Fund rankings while having the worst specialty waiting times among peer nations, proving system performance is multidimensional"
+confidence: likely
+source: "UK Parliament Public Accounts Committee, BMA, NHS England reports (2024-2025); Commonwealth Fund Mirror Mirror 2024"
+created: 2025-01-15
+---
+
+# NHS demonstrates universal coverage can coexist with poor specialty outcomes because primary care, equity, and specialty access are independent dimensions
+
+The NHS paradox reveals that healthcare system performance is fundamentally multidimensional. The NHS achieves universal coverage, strong primary care, and high equity scores—earning it a 3rd place ranking in the Commonwealth Fund's Mirror Mirror 2024 comparison. Yet simultaneously, it has the worst specialty access among peer nations: only 58.9% of 7.5 million waiting patients are seen within 18 weeks (target: 92%), 22% wait over 6 weeks for diagnostic tests (standard: 1%), and some specialties have seen 263% increases in waiting list size over a decade.
+
+This is not a contradiction—it's evidence that different system dimensions operate independently. Universal coverage solves the access-to-primary-care problem. GP gatekeeping improves primary care quality and equity. Single-payer administration achieves efficiency in billing. But none of these mechanisms solve the specialty capacity problem, which requires adequate capital funding, workforce supply, and diagnostic infrastructure.
+
+The NHS demonstrates that:
+1. Universal coverage is necessary but not sufficient for good health outcomes
+2. Gatekeeping improves primary care but creates specialty bottlenecks when underfunded
+3. Administrative efficiency doesn't translate to clinical delivery efficiency
+4. Chronic underfunding compounds exponentially (respiratory medicine: 263% wait growth; gynaecology: 223% growth)
+
+For US policy debates, this is the cautionary tale: achieving universal coverage without solving the funding-quality tradeoff produces a system that scores well on equity and primary care metrics while failing on specialty outcomes. It challenges both "single-payer solves everything" and "market competition solves everything" narratives by showing that structural design choices create unavoidable tradeoffs.
+
+## Evidence
+
+**Waiting time crisis:**
+- Only 58.9% of 7.5M patients seen within 18 weeks (target: 92%)
+- 22% wait >6 weeks for diagnostic tests (standard: 1%)
+- Waiting list must be halved to 3.4M to reach the 92% standard
+- Target of 65% within 18 weeks by March 2026 unlikely to be met
+
+**Specialty backlogs:**
+- Respiratory medicine: 263% increase in waiting list size over past decade
+- Gynaecology: 223% increase
+- Shortfall of 3.6 million diagnostic tests
+- Billions spent on recovery programs without outcomes improvement
+
+**Overall ranking vs specialty performance:**
+- Ranked 3rd overall in Commonwealth Fund Mirror Mirror 2024
+- Worst specialty access among peer nations
+- Longest waits, poorest cancer outcomes
+- High scores on universal coverage, primary care, equity
+
+**Structural issues:**
+- Chronic capital underfunding relative to demand
+- Workforce shortages in specialist care
+- High competition for specialty training positions
+
+## Relationship to KB
+
+This claim directly connects to [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]—the NHS case shows that even when medical care access is universal and equitable, specialty care bottlenecks limit the system's ability to deliver the 10-20% of health outcomes that medical care can influence.
+
+The NHS paradox also illustrates why [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]—structural underfunding means that even with universal coverage, the system cannot deliver value because capacity constraints prevent timely specialty intervention.
+
+---
+
+Relevant Notes:
+- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]
+- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]
+- [[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]]
+
+Topics:
+- [[domains/health/_map]]

domains/health/nhs-demonstrates-universal-coverage-without-adequate-funding-produces-excellent-primary-care-but-worst-specialty-access-among-peer-nations.md

@@ -1,56 +0,0 @@
----
-type: claim
-domain: health
-description: "NHS ranks 3rd overall in Commonwealth Fund rankings while having the longest specialty wait times, showing universal coverage is necessary but not sufficient for good health outcomes"
-confidence: likely
-source: "UK Parliament Public Accounts Committee, BMA, NHS England (2024-2025); Commonwealth Fund Mirror Mirror 2024"
-created: 2026-03-11
-secondary_domains: [grand-strategy]
----
-
-# NHS demonstrates universal coverage without adequate funding produces excellent primary care but worst specialty access among peer nations
-
-The NHS paradox reveals that different healthcare system dimensions can move in opposite directions simultaneously. Despite ranking **3rd overall** in the Commonwealth Fund Mirror Mirror 2024 assessment, the NHS has:
-
-- Only **58.9%** of 7.5M waiting patients seen within 18 weeks (target: 92%)
-- **22%** of patients waiting >6 weeks for diagnostic tests (standard: 1%)
-- Worst specialty access among peer nations in Mirror Mirror comparison
-- Poorest cancer outcomes in the comparison set
-
-Yet the same system achieves high marks for:
-- Universal coverage with strong equity
-- Primary care quality and accessibility
-- Administrative efficiency through single-payer structure
-
-This demonstrates that universal coverage is a necessary but not sufficient condition for good health outcomes. The NHS proves you can solve the coverage problem while creating severe specialty access bottlenecks.
-
-## Evidence
-
-**Waiting time crisis:**
-- Waiting list must be **halved to 3.4 million** to reach the 92% standard
-- Target of 65% within 18 weeks by March 2026 unlikely to be met
-- Shortfall of **3.6 million diagnostic tests**
-
-**Specialty degradation over time:**
-- Respiratory medicine: **263% increase** in waiting list size over past decade
-- Gynaecology: 223% increase
-- Trauma/orthopaedics and ENT: largest waiting times
-- Billions spent on recovery programs without outcomes improvement
-
-**Structural causes:**
-- Chronic capital underfunding relative to demand
-- Workforce shortages in specialist care
-- GP gatekeeping improves primary care but creates specialty bottlenecks
-
-## Why this matters
-
-The Commonwealth Fund methodology weights access, equity, and primary care more heavily than specialty outcomes, which explains the apparent contradiction. This reveals that different stakeholders measuring "healthcare system quality" will reach different conclusions based on which dimensions they prioritize. For US policy debates, the NHS demonstrates that neither "single-payer solves everything" nor "market competition solves everything" is accurate—universal coverage solves coverage but not specialty access, and both systems face tradeoffs.
-
----
-
-Relevant Notes:
-- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]] — the NHS paradox matters less than it appears if medical care is only 10-20% of outcomes
-- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] — NHS shows what happens when payment structure doesn't align with specialty delivery
-
-Topics:
-- [[domains/health/_map]]

domains/health/the healthcare cost curve bends up through 2035 because new curative and screening capabilities create more treatable conditions faster than prices decline.md

@@ -31,12 +31,6 @@ The fundamental tension in healthcare economics: medicine can now cure diseases
 
 The composition of spending shifts dramatically: less on chronic disease management (diabetes complications, repeat cardiovascular events, lifelong hemophilia factor), more on curative interventions (gene therapy, personalized vaccines), prevention (MCED screening, GLP-1s), and new care categories. Per-capita health outcomes improve substantially, but per-capita spending also increases. The deflationary equilibrium is real but 15-20 years away, not 5-10.
 
-
-### Additional Evidence (extend)
-*Source: [[2025-00-00-nhs-england-waiting-times-underfunding]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
-
-(Extend) The NHS provides a cautionary case for the cost curve claim: when capability expansion (new diagnostics, new treatments) meets funding constraint, the result is not cost control but access rationing. The NHS has a shortfall of 3.6 million diagnostic tests and waiting lists that must be halved (from 7.5M to 3.4M) to reach target. This suggests that in single-payer systems with hard budget constraints, the cost curve bending up manifests as wait time expansion rather than expenditure growth—the same underlying dynamic (more treatable conditions) with different system responses. In the US context with softer budget constraints, the cost curve bends up through spending; in the NHS with hard constraints, it bends up through rationing.
-
 ---
 
 Relevant Notes:

domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md

@@ -23,12 +23,6 @@ The Making Care Primary model's termination in June 2025 (after just 12 months,
 
 PACE represents the extreme end of value-based care alignment—100% capitation with full financial risk for a nursing-home-eligible population. The ASPE/HHS evaluation shows that even under complete payment alignment, PACE does not reduce total costs but redistributes them (lower Medicare acute costs in early months, higher Medicaid chronic costs overall). This suggests that the 'payment boundary' stall may not be primarily a problem of insufficient risk-bearing. Rather, the economic case for value-based care may rest on quality/preference improvements rather than cost reduction. PACE's 'stall' is not at the payment boundary—it's at the cost-savings promise. The implication: value-based care may require a different success metric (outcome quality, institutionalization avoidance, mortality reduction) than the current cost-reduction narrative assumes.
 
-
-### Additional Evidence (extend)
-*Source: [[2025-00-00-nhs-england-waiting-times-underfunding]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
-
-(Extend) The NHS demonstrates what happens when payment structure (single-payer, capitated GP funding) doesn't align with specialty delivery incentives. Despite billions spent on 'recovery programs' and 'transformation initiatives,' waiting times continued to degrade exponentially (263% growth in respiratory, 223% in gynaecology over a decade). The payment boundary problem manifests as: GPs are paid to coordinate and gatekeep, but specialists face capacity constraints without payment incentives to expand. This creates a structural bottleneck where value-based primary care coexists with volume-constrained specialty care. The NHS shows that payment misalignment at the specialty interface prevents system-wide value optimization even when primary care payment is well-aligned.
-
 ---
 
 Relevant Notes:

inbox/archive/2025-00-00-nhs-england-waiting-times-underfunding.md

@@ -12,10 +12,10 @@ priority: medium
 tags: [nhs, universal-coverage, waiting-times, underfunding, international-comparison, uk-healthcare]
 processed_by: vida
 processed_date: 2026-03-11
-claims_extracted: ["nhs-demonstrates-universal-coverage-without-adequate-funding-produces-excellent-primary-care-but-worst-specialty-access-among-peer-nations.md", "chronic-underfunding-of-healthcare-capital-compounds-exponentially-as-263-percent-respiratory-wait-growth-demonstrates.md", "gatekeeping-through-gp-referral-requirements-improves-primary-care-quality-but-creates-specialty-access-bottlenecks.md"]
-enrichments_applied: ["medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md", "the healthcare cost curve bends up through 2035 because new curative and screening capabilities create more treatable conditions faster than prices decline.md"]
+claims_extracted: ["nhs-demonstrates-universal-coverage-can-coexist-with-poor-specialty-outcomes-because-primary-care-equity-and-specialty-access-are-independent-dimensions.md", "gatekeeping-primary-care-models-improve-equity-and-primary-outcomes-but-create-specialty-bottlenecks-when-capacity-is-underfunded.md"]
+enrichments_applied: ["medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md"]
 extraction_model: "anthropic/claude-sonnet-4.5"
-extraction_notes: "Extracted three claims about the NHS paradox (universal coverage + poor specialty outcomes), exponential degradation from chronic underfunding, and gatekeeping tradeoffs. Applied three enrichments connecting to existing claims about medical care contribution to outcomes, value-based care payment boundaries, and healthcare cost curves. The NHS case is a natural experiment showing how universal coverage, strong primary care, and catastrophic specialty access can coexist — a cautionary tale for both single-payer advocates and market competition advocates."
+extraction_notes: "Extracted two claims about the NHS paradox: (1) universal coverage can coexist with poor specialty outcomes because these are independent dimensions, and (2) gatekeeping models create specialty bottlenecks when underfunded. Enriched the medical care 10-20% claim with NHS evidence showing that specialty access constraints limit medical care's contribution to health outcomes even when primary care is universal. The NHS case is significant because it provides a natural experiment in what universal coverage achieves (primary care equity) and what it doesn't (specialty access), challenging both single-payer and market-competition narratives in US policy debates."
 ---
 
 ## Content
@@ -69,9 +69,11 @@ EXTRACTION HINT: The paradox of ranking 3rd overall while having worst specialty
 
 
 ## Key Facts
-- NHS waiting list: 7.5M patients, only 58.9% seen within 18-week target (goal: 92%)
-- NHS diagnostic backlog: 3.6 million tests behind demand
-- NHS respiratory wait times: 263% increase over past decade
-- NHS gynaecology wait times: 223% increase over past decade
-- NHS Commonwealth Fund ranking: 3rd overall in Mirror Mirror 2024
-- NHS specialty access: worst among peer nations in Mirror Mirror comparison
+- NHS waiting list: 7.5M patients, only 58.9% seen within 18 weeks (target: 92%)
+- 22% of patients wait >6 weeks for diagnostic tests (standard: 1%)
+- Respiratory medicine waiting list: 263% increase over past decade
+- Gynaecology waiting list: 223% increase over past decade
+- Shortfall of 3.6 million diagnostic tests
+- NHS ranked 3rd overall in Commonwealth Fund Mirror Mirror 2024
+- Target of 65% within 18 weeks by March 2026 unlikely to be met
+- Waiting list must be halved to 3.4M to reach the 92% standard